As of 2025-07-19, the EV/EBITDA ratio of Maravai LifeSciences Holdings Inc (MRVI) is -165.60. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRVI's latest enterprise value is 660.42 mil USD. MRVI's TTM EBITDA according to its financial statements is -3.99 mil USD. Dividing these 2 quantities gives us the above MRVI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.2x - 15.6x | 14.6x |
| Forward P/E multiples | 16.6x - 22.6x | 19.0x |
| Fair Price | (0.42) - (0.41) | (0.43) |
| Upside | -117.4% - -116.8% | -117.5% |
| Date | EV/EBITDA |
| 2025-07-18 | -165.60 |
| 2025-07-17 | -170.71 |
| 2025-07-16 | -171.35 |
| 2025-07-15 | -175.82 |
| 2025-07-14 | -180.93 |
| 2025-07-11 | -184.76 |
| 2025-07-10 | -194.98 |
| 2025-07-09 | -186.68 |
| 2025-07-08 | -186.68 |
| 2025-07-07 | -176.46 |
| 2025-07-03 | -180.93 |
| 2025-07-02 | -179.65 |
| 2025-07-01 | -170.71 |
| 2025-06-30 | -164.33 |
| 2025-06-27 | -168.16 |
| 2025-06-26 | -162.41 |
| 2025-06-25 | -155.39 |
| 2025-06-24 | -152.83 |
| 2025-06-23 | -145.17 |
| 2025-06-20 | -141.98 |
| 2025-06-18 | -138.78 |
| 2025-06-17 | -143.89 |
| 2025-06-16 | -148.36 |
| 2025-06-13 | -146.45 |
| 2025-06-12 | -154.75 |
| 2025-06-11 | -156.02 |
| 2025-06-10 | -148.36 |
| 2025-06-09 | -156.02 |
| 2025-06-06 | -163.05 |
| 2025-06-05 | -149.00 |
| 2025-06-04 | -151.55 |
| 2025-06-03 | -152.19 |
| 2025-06-02 | -146.45 |
| 2025-05-30 | -154.11 |
| 2025-05-29 | -161.77 |
| 2025-05-28 | -151.55 |
| 2025-05-27 | -152.83 |
| 2025-05-23 | -152.19 |
| 2025-05-22 | -156.98 |
| 2025-05-21 | -154.11 |
| 2025-05-20 | -163.69 |
| 2025-05-19 | -149.00 |
| 2025-05-16 | -144.53 |
| 2025-05-15 | -135.59 |
| 2025-05-14 | -136.87 |
| 2025-05-13 | -141.98 |
| 2025-05-12 | -145.81 |
| 2025-05-09 | -136.87 |
| 2025-05-08 | -142.61 |
| 2025-05-07 | -145.81 |